Drugs became widespread through a combination of international trade, pharmaceutical industrialization, aggressive marketing, and social forces that unfolded over roughly two centuries. No single event explains it. Instead, a series of overlapping developments, each building on the last, created a world where both legal and illegal substances are deeply embedded in daily life. About 60% of American adults take at least one prescription drug regularly, the global illegal drug trade generates hundreds of billions of dollars annually, and antidepressant use across developed nations has climbed steadily for decades. Understanding how we got here means tracing several threads at once.
Colonial Trade Built the First Global Drug Market
The story starts with opium. In the early 1800s, British merchants discovered a massive market for smuggled opium in southern China. American traders quickly followed, using opium to supplement their exports. The scale of this trade was so enormous that it reversed China’s balance of trade for the first time in history: a country that had always exported more than it imported was suddenly running a deficit, largely because of a single addictive substance. The financial and political fallout led directly to the First Opium War between Great Britain and China from 1839 to 1842.
This wasn’t a fringe black market operation. It was state-backed commerce. The British Empire fought a war specifically to keep the opium trade open. That precedent matters because it established a pattern that would repeat itself: powerful economic interests driving the widespread distribution of addictive substances, with governments either participating or looking the other way.
Pharmaceutical Companies Packaged Addiction as Medicine
The late 19th and early 20th centuries saw a shift from raw plant-based drugs to refined, branded products sold by corporations. In 1898, Bayer introduced heroin as a pain reliever and cough suppressant. The company packaged it in amber glass bottles with colorful labels, presenting it to customers as a safe, effective treatment. Heroin was stronger and cheaper than morphine, which made it attractive to both doctors and patients. It was also far more addictive, a fact that took years to be widely acknowledged.
This era established something crucial: the role of industrial-scale manufacturing and marketing in making drugs accessible to millions of people who would never have encountered them otherwise. When a trusted company puts a substance in a professional-looking bottle and a doctor recommends it, the barrier to use effectively disappears. The same dynamic would play out again nearly a century later with prescription opioids.
The Push to Treat Pain Changed Prescribing Culture
In 1995, Dr. James Campbell addressed the American Pain Society and urged healthcare providers to treat pain as the “fifth vital sign,” alongside temperature, pulse, blood pressure, and breathing rate. The idea was well-intentioned: pain was genuinely undertreated, and patients were suffering unnecessarily. But the practical effect was a dramatic increase in the prescribing of powerful painkillers. Hospitals and clinics began measuring patient satisfaction partly on how well their pain was managed, which created pressure to prescribe more aggressively.
Pharmaceutical companies seized this moment. They marketed opioid painkillers directly to doctors, often downplaying the risk of addiction. The result was a flood of prescription opioids into communities across the United States that fed directly into the addiction crisis of the 2000s and 2010s. Many people who became dependent on heroin or illicit synthetic opioids started with a legitimate prescription after surgery or an injury.
Billions in Advertising Keep Demand High
The United States is one of only two countries in the world (along with New Zealand) that allows pharmaceutical companies to advertise prescription drugs directly to consumers. Drug manufacturers spent roughly $6 billion per year on this kind of advertising from 2016 through 2018, covering 553 different drugs. That spending was spread across television, digital media, and print, and it was remarkably consistent year over year, totaling $17.8 billion over that three-year period.
This advertising doesn’t just inform people about available treatments. It actively shapes how people think about their health. When you see a commercial suggesting you “ask your doctor” about a medication for a condition you may not have previously considered treatable, it creates demand. Doctors report that patients frequently request specific brand-name drugs they saw advertised, and many of those requests are fulfilled. This cycle of advertising, patient demand, and prescribing is a major driver of how normalized pharmaceutical drug use has become in everyday life.
Social Environment Shapes Who Uses What
Drug use doesn’t happen in a vacuum. The social environments people move through, especially during transitional periods, play a significant role in whether and how often they encounter substances. College is a clear example. The shift to emerging adulthood brings reduced supervision, new peer groups, and growing independence in decision-making, all of which converge to increase substance use risk. College environments tend to normalize drug and alcohol use and provide increased access.
Where you grew up matters too. Research tracking students from urban and rural backgrounds found consistent differences in substance exposure. Among freshmen, 83% of urban students reported that their closest friends used alcohol, compared to 72% of rural students. For marijuana, the gap was similar: 37% of urban students versus 28% of rural students reported close friends who used it. By sophomore year, those gaps widened further. These aren’t differences in individual vulnerability. They reflect differences in availability and social norms, two of the strongest predictors of whether someone will use a substance.
International Law Created Both Control and Black Markets
By the mid-20th century, governments recognized that the global drug trade needed coordinated regulation. The Single Convention on Narcotic Drugs of 1961 aimed to limit the production, manufacture, trade, and use of drugs “exclusively to medical and scientific purposes.” It brought together controls on opium, cannabis, cannabis resin, and the wave of synthetic drugs that had emerged during the 1940s. Cannabis was placed in the convention’s most restrictive category, effectively recommending that countries prohibit even its medical use.
The convention created a framework for international drug control that still shapes policy today. But prohibition had a well-documented side effect: it created enormous profit margins for anyone willing to operate outside the law. When legal supply is restricted but demand persists, black markets fill the gap. The global illegal drug trade now generates hundreds of billions of dollars annually, funding criminal organizations with the resources to maintain sophisticated production and distribution networks that span continents. In many ways, the attempt to control drugs through prohibition contributed to their spread by making drug trafficking one of the most profitable enterprises on earth.
Prescription Use Keeps Climbing Worldwide
Even setting aside illegal drugs, the sheer volume of legal pharmaceutical use has grown dramatically. Across developed nations, antidepressant consumption rose steadily from 2010 to 2020, with the average dose per 1,000 people climbing from 52.42 to 69.5 defined daily doses. That increase occurred in nearly every country tracked by the Organisation for Economic Co-operation and Development, with only Denmark and Norway bucking the trend. Some countries, including Canada, Estonia, Finland, Greece, Italy, Latvia, and Portugal, showed exponential rather than linear growth, meaning the rate of increase was itself accelerating.
Australia had the steepest climb, while a handful of countries like Austria and the United Kingdom appeared to be approaching a plateau. Countries with consistently high consumption included Australia, Canada, Iceland, Sweden, and the UK. This isn’t solely a story about overprescription. It also reflects genuine improvements in diagnosing conditions like depression and anxiety, reduced stigma around mental health treatment, and broader access to healthcare. But the trend is unmistakable: pharmaceutical drugs are more embedded in daily life in developed countries than at any point in human history.
Why It All Compounds
What makes drug prevalence so hard to reverse is that none of these factors operate in isolation. Colonial trade routes established supply chains. Industrialization made mass production possible. Marketing created demand. Social environments normalized use. International prohibition generated massive criminal economies. And the medicalization of everyday suffering expanded the definition of who “needs” a drug. Each layer reinforced the others, creating a system where both legal and illegal substances flow through society with remarkable efficiency. The question isn’t really why drugs became widespread. Given the economic incentives, the social pressures, and the basic human desire to feel better, the more surprising outcome would have been if they hadn’t.